TY - JOUR
T1 - ¿Cuáles son los factores predictores de fracaso de ventilación no invasiva más fiables en una unidad de cuidados intensivos pediátricos?
AU - Pons-Òdena, Martí
AU - Medina, Alberto
AU - Modesto, Vicente
AU - Martín-Mateos, María Anunciación
AU - Tan, Wooi
AU - Escuredo, Laura
AU - Cambra, Francisco José
N1 - Publisher Copyright:
© 2019 Asociación Española de Pediatría
PY - 2019/11
Y1 - 2019/11
N2 - Introduction: Despite there being limited evidence, non-invasive ventilation (NIV) has become a common treatment for acute respiratory failure (ARF). The aim of this study was to identify the predictive factors of NIV failure, in order to enable early detection of patients failing the treatment. Patients and methods: Prospective cohort study was conducted that included all ARF patients that received NIV as the initial treatment between 2005 and 2009 in a fourteen-bed Paediatric Intensive Care Unit (PICU) of a tertiary university hospital. Information was collected about the NIV, as well as clinical data prior to NIV, at 2, 8, 12, and 24 hrs. The haemoglobin saturation (SpO2)/fraction of inspired oxygen (FiO2) ratio (S/F) was retrospectively calculated. NIV failure was defined as the need for intubation or requiring rescue with bi-level pressure (BLPAP). Univariate and multivariate statistical analyses were performed. Results: A total of 282 patients received non-invasive support, with 71 receiving Continuous Pressure (CPAP), and 211 with BLPAP treatment. The overall success rate was 71%. Patients receiving BLPAP vs. CPAP, patients with higher S/F ratios at 2 hours (odds ratio [OR] 0.991, 95% CI 0.986-0.996, P = .001], and patients older than 6 months (Hazard ratio [HZ] 0.375, 95% CI 0.171-0.820, P = .014], were also more likely to fail. Patients with higher heart rates (HR) at 2 hours (OR 1.021, 95% CI [1.008-1.034], P = .001) and higher inspiratory positive airway pressure (IPAP) at 2 hours were more prone to failure (HZ 1.214, 95% CI [1.046-1.408], P = .011). Conclusions: Age below 6 months, S/F ratio, HR, and IPAP at 2 hours are independent predictive factors for initial NIV failure in paediatric patients with ARF admitted to the PICU.
AB - Introduction: Despite there being limited evidence, non-invasive ventilation (NIV) has become a common treatment for acute respiratory failure (ARF). The aim of this study was to identify the predictive factors of NIV failure, in order to enable early detection of patients failing the treatment. Patients and methods: Prospective cohort study was conducted that included all ARF patients that received NIV as the initial treatment between 2005 and 2009 in a fourteen-bed Paediatric Intensive Care Unit (PICU) of a tertiary university hospital. Information was collected about the NIV, as well as clinical data prior to NIV, at 2, 8, 12, and 24 hrs. The haemoglobin saturation (SpO2)/fraction of inspired oxygen (FiO2) ratio (S/F) was retrospectively calculated. NIV failure was defined as the need for intubation or requiring rescue with bi-level pressure (BLPAP). Univariate and multivariate statistical analyses were performed. Results: A total of 282 patients received non-invasive support, with 71 receiving Continuous Pressure (CPAP), and 211 with BLPAP treatment. The overall success rate was 71%. Patients receiving BLPAP vs. CPAP, patients with higher S/F ratios at 2 hours (odds ratio [OR] 0.991, 95% CI 0.986-0.996, P = .001], and patients older than 6 months (Hazard ratio [HZ] 0.375, 95% CI 0.171-0.820, P = .014], were also more likely to fail. Patients with higher heart rates (HR) at 2 hours (OR 1.021, 95% CI [1.008-1.034], P = .001) and higher inspiratory positive airway pressure (IPAP) at 2 hours were more prone to failure (HZ 1.214, 95% CI [1.046-1.408], P = .011). Conclusions: Age below 6 months, S/F ratio, HR, and IPAP at 2 hours are independent predictive factors for initial NIV failure in paediatric patients with ARF admitted to the PICU.
KW - Bronchiolitis
KW - Non-invasive ventilation
KW - Paediatric intensive care units
KW - Respiratory failure
UR - http://www.scopus.com/inward/record.url?scp=85061747612&partnerID=8YFLogxK
U2 - 10.1016/j.anpedi.2019.01.013
DO - 10.1016/j.anpedi.2019.01.013
M3 - Artículo
C2 - 30797702
AN - SCOPUS:85061747612
SN - 1695-4033
VL - 91
SP - 307
EP - 316
JO - Anales de pediatría
JF - Anales de pediatría
IS - 5
ER -